Related Experiment Video
Updated: Aug 11, 2026
Direct Intraventricular Delivery of Drugs to the Rodent Central Nervous System
Published on: May 12, 2013
Antisense oligonucleotides for target validation in the CNS
1DuPont Pharmaceuticals, Wilmington, DE 19880, USA. siew.p.ho@dupontpharma.com
Abstract:
Although antisense oligonucleotides have been used in cell-based antisense experiments for nearly two decades, studies to investigate the function of CNS proteins in living animals were not successfully conducted until recently. Oligonucleotides are not transported across the blood-brain barrier to any appreciable extent. Consequently, these molecules need to be administered directly into the brain. Antisense approaches may be especially suited to investigation of CNS proteins. Due to their specificity, antisense sequences can more easily and selectively distinguish between closely related proteins, such as receptor subtypes, in contrast to the more traditional pharmacological agents such as small molecule ligands. This review discusses some unique technical aspects surrounding oligonucleotide delivery to the brain, and summarizes some of the more noteworthy applications of antisense tools to the study of CNS protein function during the past two years.
Insights
Antisense oligonucleotides offer a specific method for studying central nervous system (CNS) protein function in vivo. Direct brain delivery is required due to the blood-brain barrier, enabling precise investigation of CNS proteins.
Area of Science:
- Neuroscience
- Molecular Biology
- Pharmacology
Background:
- Antisense oligonucleotides (ASOs) have been utilized in cell-based studies for two decades.
- Investigating central nervous system (CNS) protein function in living animals using ASOs has been challenging.
- ASOs do not readily cross the blood-brain barrier, necessitating direct administration into the brain.
Purpose of the Study:
- To review technical challenges and recent advancements in delivering antisense oligonucleotides to the brain.
- To summarize the application of antisense tools in studying CNS protein function in vivo.
- To highlight the specificity of antisense approaches for distinguishing closely related CNS proteins.
Main Methods:
- Review of existing literature on oligonucleotide delivery to the brain.
- Summary of recent studies employing antisense technology for CNS protein research.
- Discussion of the unique properties of antisense sequences in targeting specific proteins.
Main Results:
- Recent successful investigations of CNS protein function in vivo using antisense approaches.
- Demonstration of the specificity of antisense sequences for differentiating related proteins (e.g., receptor subtypes).
- Identification of key technical aspects for effective oligonucleotide delivery to the brain.
Conclusions:
- Antisense oligonucleotides are valuable tools for studying CNS protein function in animal models.
- Direct brain administration is crucial for effective ASO-mediated gene silencing in the CNS.
- Antisense technology provides a highly specific alternative to traditional pharmacological agents for CNS research.
